Healthsonix Inc. DL-,001

warte mal auf nächste woche.
Was runter geht, geht auch wieder rauf. lg. limi  

.....und die Hymne: wenn nicht diese Woche ,dann nächste Woche....  

HealthSonix Files International PCT Patent Application for Its Sound Pressure Wave Technology


2006-11-01 08:00 ET - News Release

IRVINE, CA -- (MARKET WIRE) -- 11/01/06


HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that the company has filed a Patent Cooperation Treaty (PCT) application to reserve the right to later file foreign patent applications in other key markets around the world. With this filing, future applications will be accorded the same effective filing date as the US patent application.

"The enSonix and AquaSonix line of medical products rely on our unique sound pressure wave technology which represents a medical breakthrough in the fight against the pain of arthritis. Protecting that intellectual property remains a high priority and HealthSonix will use its resources to ensure that our products receive the strongest protection possible around the world," stated Dieter Doederlein, Vice President of Corporate Development.

The Patent Cooperation Treaty (PCT) was established to provide an efficient and cost-effective way to enter into the patenting process in many different countries at one time. Most of the countries in the world are signatories to the Paris Convention. The PCT permits the filing of an "international" patent application either immediately or within one year of the filing of a patent application in any of the member nations. This filing now gives HealthSonix the ability to file for additional international patents over the next 18 months while retaining the original US priority filing date.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves have proven to be 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.

More information regarding HealthSonix and its products and services can be found at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.


Contact:
Dieter D. Doederlein
1-877-622-2121
Email Contact




mfg BoMa  

mmm tut sich nichts mehr wird dann wohl doch eine längerfristige Anlage werden.  

günstig zu haben und mit Tendenz steigend  

die gibts nachher auch noch günstig.:)  

wahnsinnig erfolgversprechenden Scheine hast Du denn, petrusschen ?

mfg BoMa  

sag Du erst!:)  

doch weißt, was günstig zu kaufen ist, lasse ich Dir den Vortritt. Wir anderen sind hier halt noch nicht so fit, weißte...

mfg BoMa  

Wer sind bitteschön "wir anderen"? Falls Du Dich an meinen Post störst, der war an Buran gerichtet.  

* ... *
 

kann man aber auch gleich sagen wenn es Dich stört...  

ja dann mach doch mal eine Ansage, die deutlich ausdrückt, was Du meinst. Willst Du hier einsteigen und zu welchem Kurs ?  Oder bist Du schon mit an, wie buran sagen würde ?

Wäre doch mal interessant zu wissen.  

Wenn es unter 0,20 was gibt, nehme ich eine Kleinigkeit. Vielleicht.  

es ist doch gleich feierabend... nur die ruhe ...
lg. limi  

Richtung.Das wäre doch nicht zuviel verlangt.Etwas hoch mit den teuren Hintern ,ein kleinwenig anheben.  

schon wieder Einstiegskurse.Unter0,20 kann man nicht viel verkehrt machen.
Unsere Gesundheit kann sich ja nicht viel verschlechtert haben in den letzten
14 Tagen,wenn ich mir den Kurs so anschaue.  

Die Experten vom "Oberbayerischen Börsenbrief" stufen die Aktie von HealthSonix mit "strong buy" ein. Das Kursziel liege bei 5,00 EUR, was einem Kurspotenzial von rund 400% entspreche. (20.09.2006/ac/a/a)



Quelle: aktiencheck.de  

Wo sind wir gelandet?
--------------------
Times & Sales

Zeit Kurs  Stück  
13:43:10 0,22  7.500  
09:41:33 0,24  0  
-------------------
Letzter   Vortag  Umsatz   Veränderung  
0,22  0,25  1.650  -12,00%  
Börsenplatz: Frankfurt Stand: 13:43


 

...ich werd schön nochmal nachkaufen.

mfg BoMa  

Das meine lieben Leute ist einfach meine Göttin ,die BoMa.Reich intelligent und VERMÖGEND ,der Mann der sie sich sein eigen nennt ,darf sich glücklich schätzen.  

ob der sich so glücklich schätzen dürfte...   BoMa ist  G E I Z I G      *gg*

 

HealthSonix Commences New Clinical Trials to Expand Medical Claims for AquaSonix Therapy
Thursday November 9, 11:30 am ET


IRVINE, CA--(MARKET WIRE)--Nov 9, 2006 -- HealthSonix, Inc. (Other OTC:HSXI.PK - News) (Frankfurt:H7S.F - News) today announced it has commenced a new AquaSonix Therapy clinical trial with patients suffering with pain from osteoarthritis of the knee. The study group has been randomly divided into two groups: one group receives the actual sound pressure wave treatments, while the second control or placebo group, does not.
ADVERTISEMENT


"This clinical study is a Prospective, Randomized, Double-Blind, Single-Centre, Eight Week Trial to Baseline," stated Dr. David Venturi, Medical Director of HealthSonix. "The study will examine pain, function and stiffness levels using the WOMAC questionnaire and life style changes using the SF36 instrument to monitor the patient\'s progress after 5 and 10 and 15 treatment sessions. A physician\'s examination and radiographs have been used to establish the osteoarthritis of the knee diagnosis."

"This study is part of our on-going research efforts to gather more condition-specific scientific evidence for our patent pending sound pressure wave technology, and thereby initiate application of additional medical claims, for disease specific chronic and acute pain conditions," added Dr. Venturi.

AquaSonix Therapy is a breakthrough medical treatment for people with pain, reduced mobility and diminishing flexibility. It\'s a therapeutic water program that combines sound pressure waves with individualized low impact exercises in warm water therapy pools.

HealthSonix, Inc. (Other OTC:HSXI.PK - News) (Frankfurt:H7S.F - News) is a publicly traded medical technology company. The Company\'s core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.

More information regarding HealthSonix and its products and services can be found at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.



Contact:
Contact:
Dieter D. Doederlein
1-877-622-2121
Email Contact
 

schaffen wir heute noch 13%?!
@Matze: Dank Dir Gr.buan  

besser .-)).

Glaube nicht, daß es hier in absehbarer Zeit sprunghaft nach oben gehen wird, weil die Zocker erstmal draußen sind.

mfg BoMa